| Zoraida Michelle Price, LMHC | |
|
195 Ne Gilman Blvd Ste 100, Issaquah, WA 98027-2940 | |
| (425) 295-7697 | |
| (818) 279-2296 |
| Full Name | Zoraida Michelle Price |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 195 Ne Gilman Blvd Ste 100, Issaquah, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124584511 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 03025 (Kansas) | Secondary |
| 101YM0800X | Counselor - Mental Health | LH61357823 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Zoraida Michelle Price, LMHC 195 Ne Gilman Blvd Ste 100, Issaquah, WA 98027-2940 Ph: (425) 295-7697 | Zoraida Michelle Price, LMHC 195 Ne Gilman Blvd Ste 100, Issaquah, WA 98027-2940 Ph: (425) 295-7697 |
News Archive
In conjunction with National Respiratory Care Week, Contour Products(TM), a leader in the sleep support and comfort industry, is proud to promote the results of a 2009 survey conducted among respiratory therapists who work with CPAP patients daily. One of the most common issues among CPAP therapy users is discomfort when sleeping with their CPAP mask, as a result of the mask pressing against their face.
Ebstein's anomaly is a rare congenital valvular heart disease. Now, in patients with this disease, researchers of the Academic Medical Center Amsterdam in the Netherlands, the University of Newcastle, UK and the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch have identified mutations in a gene which plays an important role in the structure of the heart.
A prototype for wearable equipment to support human motion has been developed at Hiroshima University, Japan. This wearable equipment, called the Sensorimotor Enhancing Suit (SEnS), enhances sensorimotor functions by reducing the muscle load of the upper limbs.
Elsevier and MyScienceWork collaborate to enable users to access wealth of full text articles outside of ScienceDirect.
Precision medicine - in which diagnosis and treatments are keyed to the genetic susceptibilities of individual cancers - has advanced to the point where it can now impact the care of a majority of children with brain tumors, a new study by investigators at Dana-Farber/Boston Children's Cancer and Blood Disorders Center suggests.
› Verified 1 days ago